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Stem cells can be derived from the embryo (embryonic stem cells, ESCs), from adult tissues (adult stem cells, ASCs), 
and by induction of fibroblasts (induced pluripotent stem cells, iPSs). Ethical problems, immunological rejection, and 
difficulties in obtaining human tissues limit the use of ESCs in clinical medicine1-2. Induced pluripotent stem cells are 
difficult to maintain in vitro and carry a greater risk of tumor formation. Furthermore, the complexity of maintenance 
and propagation is especially difficult in the clinic3-10. Adult stem cells can be isolated from several adult tissues and 
present the possibility of self-transplantation for the clinical treatment of a variety of human diseases. Recently, 
several ASCs have been successfully isolated and cultured in vitro, including hematopoietic stem cells (HSCs) 11, 
mesenchymal stem cells (MSCs) 12-13, epidermis stem cells 14, neural stem cells (NSCs) 15, adipose-derived stem cells 
(ADSCs)16, islet stem cells 17, and germ line stem cells 18-20. Human mesenchymal stem cells originate mainly from 
bone marrow 21-22, cord blood 23, and placenta 24-25, but epidermis-derived MSCs have not yet been isolated. We 
isolated small spindle-shaped cells with strong proliferative potential during the culture of human epidermis cells and 
designed a medium to isolate and propagate these cells. They resembled MSCs morphologically and demonstrated 
pluripotency in vivo; thus, we defined these cells as human epidermis-derived mesenchymal stem cell-like pluripotent 
cells (hEMSCPCs). These hEMSCPCs present a possible new cell resource for tissue engineering and regenerative 
medicine. 
 
 
Human EMSCPCs were passaged at 1:3 every 1.5~3 days and after about three months (around passage 30), at least 
2×1016 cells were obtained from a single adult tissue sample. These hEMSCPCs expressed the main markers of MSCs 
and NSCs, had good bio-safety 26, and could differentiate into neural cells 27 and immunocytes 28 under appropriate 
conditions. Furthermore, we found that hEMSCPCs cells could be reprogrammed after injection into the mouse 
blastocyst cavity to form heterogeneous chimeras. Indeed, hEMSCPC-derived cells were present in several organs of 
the postnatal mouse (1-5 months old), and expressed organ-specific functional proteins. Consequently, we have not 
only successfully isolated and cultured a new type of ASC with strong viability in vitro, but also demonstrated that 
they can be reprogrammed after blastocyst cavity injection. 
 
To obtain hEMSCPCs, we first designed a selective culture medium (supplementary methods). We obtained eight 
foreskin specimens from surgical patients who were negative for HIV, hepacivirus, and leptospira infection. After 
treating the foreskin tissue with a digestive solution (supplementary methods), the tissue was washed more than five 
times in PBS to prevent hypodermal cell contamination. The whole epithelial layer was isolated from the basilar 
membrane and treated with a digestive solution. Individual epithelial cells were then obtained by mechanical 
trituration. These epithelial cells were resuspened in hEMSCPC-specific medium and cultured in an incubator at 36.8 
± 0.2 ºC under 5% CO2 and 100% humidity. On day two, the culture medium was replaced and non-adherent cells 
were removed. Spindle-shaped cells with small cell bodies were observed after 7-10 days in vitro (Fig. 1a, P0 7d), 
While the majority of cells died. polygonal epithelial-like cells grew in some cultures. Between days 5 and 10, the 
culture medium was replaced (as indicated by acidification). When replacing the medium, dead cells were removed 
by gentle agitation with a pipetter. Spindle-shaped cells with small cell bodies gradually increased over the next days 
  
and weeks (Fig. 1a, P0 12d & P0 15d). These spindle-shaped cells with small cell bodies were harvested at two to 
three weeks in vitro as they were more easily detached from the culture plates compared to the polygonal 
epithelial-like cells. Thus, we could selectively separate this two cell types by controlling the digestion time. Isolated 
spindle-shaped cells with small cell bodies were then cultured alone in hEMSCPCs culture medium. Cells were split 
at 1:3 every 1.5-3 days (Fig. 1b, P2 3d) and they continued to proliferate rapidly up to passage 30. Most of these cells 
were short and spindle-shaped before passage 10 (Fig 1b, P2 2d), but showed greater morphological heterogeneity 
after passage 10 (Fig. 1c-e). Most cells had two to three projections (Fig 1c, round figure on the left, indicated by the 
arrow), while a few had several projections (Fig 1c, round figure on the right, indicated by the arrow). In some 
specimens, most of the hEMSCPCs had short projections and only a few had longer slender projections (Fig 1d, 
round figure on the left, indicated by the arrow), while hEMSCPCs obtained from other specimens had mostly long 
slender projections. When hEMSCPCs formed a monolayer, they took on a vortex pattern resembling MSCs (Fig. 1f). 
Chromosome detection of hEMSCPCs between passages 30 to 32 confirmed the karyotype as 46, XY 
(Supplementary Fig. 1). 
 
Past reports did not find MSCs in the epidermis, so it is uncertain where these hEMSCPCs came from. We surmised 
that epidermal stem cells might transdifferentiate into hEMSCPCs in the microenvironment supplied by the special 
medium. To investigate this possibility and to examine phenotypic changes during long-term culture, we examined 
the expression of several markers that are known to be expressed by skin-derived cells. These proteins included the 
MSC makers CD73, CD90, and CD105, the fibroblast marker vimentin, the NSC marker nestin, the neuronal marker 
β-III tubulin, the glial marker GFAP, the immunocyte markers CD3, CD19, CD16, and CD45, the HSC marker CD34, 
the epithelial cell marker CK19, the basilar membrane cell marker CD1029, the vascular endothelial cell markers 
CD31 and VEGF-R2, and the human histocompatibility antigens HLA-DR and HLA-I. 
 
We assessed expression patterns at passage 2, 10, 20, and 30 by immunohistochemisty. Only a fraction of hEMSCPCs 
expressed CD90 and nestin (Fig. 2a) at passage 2, but almost all expressed the MSC marker CD90 (Fig. 2i) and the 
NSC marker nestin (Fig. 2c) at passages 10, 20, and 30. At all passages, most hEMSCPCs cells expressed the MSC 
marker CD73 (Fig. 2j) and the fibroblast marker vimentin (Fig. 2b, d), a significant fraction expressed CD105 (Fig. 
2k), and a few cells expressed β-III tubulin, GFAP, CK19 (Fig. 2e) and CD10 (Fig. 2f). Very few expressed the 
immunocyte markers CD3 (Fig. 2g), CD19, CD16, CD45, or the HSC marker CD34. No cells at passage 2 expressed 
the vascular endothelial cells markers CD31 and VEGF-R2 (Fig. 2h), while only a few CD31 and VEGF-R2 positive 
cells were found at passages 10, 20, and 30. Interestingly, some hEMSCPCs were positive for human 
histocompatibility antigens HLA-DR and HLA-I at passage 2 (Fig. 2m), but expression decreased with passage and 
time in culture. Some cultures showed no HLA-DR-positive cells at passages 10, 20, or 30 (Fig. 2l). 
 
For quantitative analysis, we detected marker expression at passages 2, 10, 20, and 30 by flow cytometry. The results 
confirmed immunohistochemisty results except for marker CK19. Cultured hEMSCPCs expressed abundant CD73 
and vimentin, moderate CD105, low levels of β-III Tubulin, GFAP and CD10, while only sporadic cells expressed 
CD3, CD19, CD16, CD45, CD34, CD31, VEGF-R2 or CK19 at passage 2, 10, 20, and 30. Cultured hEMSCPCs 
expressed moderate CD90 and nestin at passage 2, but highly expressed CD90 and nestin at passage 10, 20, and 30. 
Expression of the human histocompatibility antigens HLA-DR and HLA-I was moderate to low at passage 2, but 
HLA-positive cells became scarce as the passage number increased. Indeed, no HLA-DR expression was observed in 
some specimens at passages 10, 20, or 30 (Fig. 3a-e and supplementary Table 1). 
 
A few CK19 positive hEMSCPCs were detected by immunohistochemisty, but no CK19 positive cell were detected 
by flow cytometry, possibly because the CK19 positive hEMSCPCs belong to the epithelial-like cells, which cannot 
be easily detached from the culture flask by digestive solutions like trypsin, so some CK19 positive cells might be 
  
lost before flow cytometry analysis. 
 
In light of these morphological, immunohistochemical, and flow cytometry results, we suggest that hEMSCPCs are 
not blood-derived because their morphological characteristics and marker expression excluded immunocytes or HSCs. 
Furthermore, these cells are not vascular endothelial cells (VEC) because they do not express the main VEC markers 
at passages 2. They are not skin-derived neural cells based on morphological characteristics and the expression of 
MSC and fibroblast markers. They are not dermis-derived MSCs or fibroblasts as we removed the dermis before 
culture and strictly controlled for contamination by hypodermal cells by washing the cuticular layers many times with 
PBS before isolation of the epithelium. In addition, hEMSCPCs are distinct from the dermis-derived MSCs and 
fibroblasts characterized previously that highly expressed the NSC marker nestin and had a tendency to take on a 
neural cell morphology. In contrast, hEMSCPCs at passages 2, 10, 20, and 30 all expressed only low levels of the 
neuronal marker β-III tubulin and the glial cell marker GFAP. Cuticular layers were isolated during primary cell 
culture, so we presume that epidermal stem cells in the basilar membrane might transdifferentiate into hEMSCPCs in 
the microenvironment supplied by the special growth medium. Immunohistochemisty revealed that hEMSCPCs at 
passages 2, 10, 20, and 30 all expressed low levels of CD10 29 and CK19, implying that hEMSCPCs are related to the 
epidermal cells of the basilar membrane. 
 
In short, hEMSCPCs were derived from epidermis but were distinct from epidermal cells; their shapes resembled 
MSCs and they expressed the main markers of MSCs and NSCs. 
 
To determine if these hEMSCPCs were multipotent in vivo like other ACSs, we injected these cells into the blastocyst 
cavity of mouse embryos and followed the development of chimeric mice. As hEMSCPCs expressed only very low 
levels of the human histocompatibility antigens HLA-DR and HLA-I, we surmised that mouse blastocyst cavity 
injection would be a viable strategy to study the behavior of these cells in vivo. We injected passage 10-13 
hEMSCPCs into the blastocyst cavity, and cultured the embryos in vitro for 13 to 15 hours. Well-developed embryos 
were transplanted into the uterus of pseudopregnant female mice and allowed to develop to term. We obtained 135 
offspring (73 male and 62 female) that grew without obvious health defects over 1-5 months. The hEMSCPCs we 
obtained were all male cells, and no marker has been identified that is specific for hEMSCPCs injected into the mice 
blastocyst cavity. Previously, we designed two primer pairs (Supplementary methods, PCR of Human SRY) specific 
for human SRY genes30 of the Y chromosomes, and used them in this study to detect the human Y chromosomes in 
blood, brain, heart, lung, spleen, liver and kidney of female mouse offspring by nested PCR. Furthermore, to validate 
the detection of the human Y chromosomes by nested PCR, we performed in situ hybridization using specific probes 
for the human Y chromosome (Supplementary methods, FISH of human Y chromosome) and examined 
immunofluorescence staining for specific markers of human blood, brain, heart, lung, spleen, liver and kidney cells 
under confocal laser scanning microscopy. 
 
Results of the nested PCR showed that 27 of 62 female offspring were positive (43.5%) for SRY genes. The 
distribution of positive organs (Supplementary Table 2) revealed that 15 of 62 (24.2%) female offspring had blood 
cells positive for SRY genes (Fig. 3f), 4 of 62 (6.5%) had SRY-positive brain tissue (Fig. 3g left), 6 of 62 (9.7%) had 
positive heart tissue (Fig. 3g right), 8 of 62 (12.9%) positive lung tissue (Fig. 3i left), 4 of 62 (6.5%) positive spleen 
tissue (Fig. 3h right), 3 of 62 (about 4.8%) positive liver tissue (Fig. 3i right), and 4 of 62 (about 6.5%) SRY-positive 
kidney (Fig. 3h left). 
 
The results of in situ hybridization confirmed results from nested PCR. Cultured hEMSCPCs and cells from caudal 
vein blood of nested PCR positive mice were analyzed by in situ hybridization. Over 90% of the hEMSCPCs were 
human Y-positive (Supplementary Fig. 2.a), and the karyocytes in the caudal vein blood of positive female off-spring 
  
had differently shaped nuclei (Supplementary Figure 2.b-e). 
 
We also used human Y-specific probes for in situ hybridization and tissue-specific antibodies for immunofluorescence 
staining to test for the presence of hEMSCPC-derived cells expressing tissue-appropriate proteins. Indeed, blood cells, 
brain cells, cardiac muscle cells, lung cells, spleen cells, liver cells, and renal glomerulus cells that were 
SYR-positive were also positive by in situ hybridization and expressed several specific human antigens (Fig. 4). 
These human-specific antigens included CD3 and CD19 in peripheral blood cells, CD16 in peripheral blood cells and 
spleen cells, MAP2 and β-III tubulin in brain cells, tropolin-I in cardiac muscle cells, SP-C and CD31 in lung cells, 
ALB in liver cells, and VEGF-R2 in renal glomerulus cells. In contrast, these specific antigens were not detected by 
immunofluorescence staining in cultured hEMSCPCs of the same passage as those injected into the blastocyst cavity, 
expect for a few cells expressing MAP2 and β-III Tubulin (results not shown). 
 
Results of in situ hybridization and immunohistochemistry in chimeric mice indicated that hEMSCPCs not only 
survived but were reprogrammed and transdifferentiated into tissue-specific phenotypes. These tissues included 
ectoderm (brain), mesoderm (blood, heart, spleen and kidney), and endoderm (lung and liver). Therefore, hEMSCPCs 
multipotent like all ASCs, can be reprogrammed by the in situ microenvironment of the mice blastocyst cavity, and 
have pluripotency to generate all three germ layers like ESCs. 
 
On the whole, we have successfully isolated and cultured a type of mesenchymal stem cells-like pluripotent cell from 
epidermis with strong proliferative ability in vitro. Past reports indicated that epidermis did not contain mesenchymal 
stem cell-like pluripotent cells, so we presume they transdifferentiated from epidermal stem cells in the special 
culture medium, although this conclusion requires additional experimental support. These hEMSCPCs could be 
injected into the mice blastocyst cavity to form heterogeneous chimeras. During mouse development, these cells 
survived, and were reprogrammed and transdifferentiated into all three germ layer cells. This chimeric model is a 
valuable tool to study the dedifferentiation of adult somatic cells in an embryonic environment and could be used to 
build heterogeneous organs in animals. The distribution of hEMSCPCs in heterogeneous animals requires further 
study. 
 
 
METHODS SUMMARY 
 
Foreskin specimens were obtained after foreskin excision surgeries. Patients were otherwise healthy as determined by 
preoperative examinations. Foreskin specimens were incubated in a digestive solution to isolate the whole cuticular 
layer and then treated with the digestive solution again to isolate epidermal cells. Cells were cultured in a medium 
specially designed to maintain short spindle-shaped and spindle-shaped mesenchymal stem cells-like cells. Cells were 
cultured and passaged over 30 times in vitro. During the culture, morphologically defined cell types were examined 
under light microscopy and by karyotype, immunostaining and immunofluorescence, and by flow cytometry analysis 
using a battery of cell-specific markers. Once hEMSCPCs were cultured to passage 10-13, dedifferentiation and 
pluripotency were examined in vivo by injecting cells into the mice blastocyst cavity and allowing chimeras to 
develop to term. Primers specific for SRY genes of the human Y chromosome were designed to detect 
hEMSCPC-derived cells by nested PCR in female chimeric mice. In situ hybridization with fluorescent probes was 
used to validate the results of nested PCR. In addition, antibodies to a variety of tissue-specific proteins of blood cells, 
brain cells, cardiac muscle cells, lung cells, spleen cells, liver cells, and renal glomerulus cells were used to detect 
tissue-appropriate expression, thereby demonstrating the transdifferentiation of hEMSCPCs in the positive organs of 
female chimeric mice. Animal-related experiments were reviewed and approved by the Laboratory Animal Care and 
Ethic Committee of Zhongshan Ophthalmology Center affiliated to Sun Yat-sen University (2010-024). 
  
 
 
 
 
 
 
 
 
 
 
 
Figure Legends 
 
 
Figure 1 ︳Morphology of cells cultured in vitro. a. When primary passage cells were cultured in vitro for 7-10 
days, small fusiform cells appeared (P0 7d), while other cell types almost completely disappeared. With prolonged 
incubation, these small fusiform cells continued to increased in number (P0 12d & P0 15d). b. Before passage 10, 
most cells were short and spindle-shaped (P2 2d). Within the first 30 passages, cells generally formed a single layer 
within 1.5-3 days after replating (P2 3d). c-e. After passage 10, most cells had short spindle or regular spindle 
morphologies, with two to three processes in most cells (c, round figure on the left, see arrow), while a minority had 
multiple processes (c, round figure on the right, see arrow). In some specimens, most of the hEMSCPCs had short 
processes, while only a minority had long and slim processes (d, round figure on the left, see arrow). In other 
specimens, however, most of the hEMSCPCs had long and slim processes. f. When hEMSCPCs formed a monolayer, 
they took on a swirling arrangement resembling that of mesenchymal stem cells. 
 
 
  
 
Figure 2 ︳Immunohistochemical staining of cell markers and immunofluorescent images. a. Some cells at P2 
showed nestin positive immunoreactivity (brown color). b. Almost all cells at P2 were vimentin positive (brown 
color). c. Almost all cells at P10, P20 and P30 showed nestin immunoreactivity (brown color). d. Almost all cells at 
P10, P20 and P30 were vimentin immunoreactive (brown color). e. At P2, P10, P20, and P30, a small number of cells 
were CK19 immunoreactive (brown color). f. At P2, P10, P20, and P30, a limited number of CD10 immunoreactivity 
cells were observed (brown color). g. At P2, P10, P20, and P30, a few individual cells were CD3 immunoreactive 
(see brown cells arrowed). h. At P2, no CD31- or VEGF R2-positive cells were seen. i. At P10, P20, and P30, almost 
all cells expressed CD90 (green fluorescence). j. At P2, P10, P20, and P30, most cells expressed CD73 (green 
fluorescence). k. At P2, P10, P20 and P30, a fraction of cells expressed CD105 (green fluorescence). I. At P10, P20, 
and P30, some specimens had no HLA-DR-positive cells. m. At P10, P20, and P30, a small number of 
HLA-I-positive cells were observed in some specimens (green fluorescence). Other markers with similar results are 
not presented. 
 
  
 
Figure 3 ︳Flow cytometry analysis of cell markers over time and electrophoretic plots from nested PCR 
detection in chimeric mice. a-e: Plots displaying flow cytometry data over time for various markers at P2, P10, P20, 
and P30. CD73 was always highly expressed at P2, P10, P20, and P30; CD90 was moderately expressed at P2, and 
highly expressed at P10, P20, and P30; CD105 was moderately expressed at P2, P10, P20 and P30. (a) Substantial 
vimentin expression was observed at P2, P10, P20, and P30. Nestin expression was consistent with CD90. It was 
moderate at P2 but high at P10, P20, and P30, whereas GFAP and β-III tubulin showed minimal expression. (b) Cell 
expressed very low levels of CD34, CD45, CD3, CD19 and CD16. (c) CD10 expression was always low, while 
CK19, CD31 and VEGF R2 were barely detectable. (d) The tissue compatibility antigens HLA-DR and HLA-I were 
moderately or lowly expressed at P2; however, with increasing number of passages, fewer and fewer cells express 
these markers. No HLA-DR-positive cells were detected in some specimens at P10, P20, and P30. (e) f-i. 
  
Electrophoretic plots displaying nested PCR of SRY gene expression in human Y chromosome in blood (f), brain (g, 
on the left), heart (g, on the right), kidney (h, on the left), spleen (h, on the right), lung (i, on the left) and liver (i, on 
the right) of chimeric mice. H2O represents negative control using ultrapure water; N represents normal mother mice 
as negative controls; P represents positive controls with hEMSCPCs, and numbers represent the identification number 
of mother mouse tested. 
 
  
 
Figure 4 ︳ FISH on human Y chromosome in chimeric mice and immunofluorescent images using 
tissue-specific antibodies. Human Y chromosome is seen as red spots, while the FITC-labeled specific antibody 
appears green. a. Peripheral blood from chimeric mice was positive for both FISH on human Y chromosome and 
  
anti-human CD3 antibody immunofluorescence. b. Peripheral blood from chimeric mice was positive for both FISH 
on human Y chromosome and anti-human CD16 antibody immunofluorescence. c. Peripheral blood from chimeric 
mice was positive for both FISH on human Y chromosome and anti-human CD19 antibody immunofluorescence. d. 
Brain tissue from chimeric mice was positive for both FISH on human Y chromosome and anti-human MAP-2 
antibody immunofluorescence. e. Brain tissue from chimeric mice was positive for both FISH on human Y 
chromosome and anti-human β-III tubulin antibody immunofluorescence. f. Cardiac tissue from chimeric mice was 
positive for both FISH on human Y chromosome and anti-human tropolin I antibody immunofluorescence. g. Lung 
tissue from chimeric mice was positive for both FISH on human Y chromosome and anti-human SP-C antibody 
immunofluorescence. h. Lung tissue from chimeric mice was positive for both FISH on human Y chromosome and 
anti-human CD31 antibody immunofluorescence. I. Splenic tissue from chimeric mice was positive for both FISH on 
human Y chromosome and anti-human CD16 antibody immunofluorescence. j. Liver tissue from chimeric mice was 
positive for both FISH on human Y chromosome and anti-human ALB antibody immunofluorescence. k. Kidney 
tissue from chimeric mice was positive for both FISH on human Y chromosome and anti-human VEGF R2 antibody 
immunofluorescence. 
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Supplementary Information 
 
Supplementary Methods 
Animal-related Experiments were reviewed and approved by the Laboratory Animal Care and Ethic Committee of 
Zhongshan Ophthalmology Center affiliated to Sun Yat-sen University (2010-024). 
Derivation of hEMSCPCs and Culture in Vitro 
Discarded prepuce tissue was obtained from healthy patients as indicated by clinical examination who underwent 
male circumcision, soaked in PBS containing 1,000 U/mL gentamycin, and was sent to the lab within one hour. The 
tissue was then stored in an 8-10℃ refrigerator for 30 min to 4 hours for subsequent treatment. First of all, prepuce 
tissue was thoroughly rinsed with PBS to remove residual blood; then loose subcutaneous tissue was resected; the 
tissue was again rinsed with PBS at least five times, in order to remove blood and tissue debris. Prepuce was cut into 
strips of 2 mm in width, or pieces of 3 mm × 3 mm in size; These strips or pieces were again rinsed with PBS for at 
least five times, to adequately remove blood and tissue debris. Prepared strips or pieces were transferred to sterilized 
  
small containers (such as 15 mL centrifugation tube), and were soaked in DispaseⅡ2U/mL DMEM solution(GIBCO, 
USA); each specimen was soaked in 6-8 mL solution, stored in a 6-8℃ refrigerator for 14-16 hours, and then 
incubated at 36.8±0.2℃ for 1 hour. Strips or pieces were placed inversely onto a sterilized plate, and washed with 
PBS at least five times, so as to adequately remove tissue debris; the layer of epidermis was tore off from dermis 
using a pair of forceps, and was placed onto another sterilized plate; the dermis is discarded; the epidermis was rinsed 
again with PBS at least five times to extensively remove tissue debris; the epidermis was cut and crushed, suspended 
with 10 mL PBS, and transferred into a 15 mL centrifugation tube; The suspension was gently pippetted and is left to 
stand for 5-10 min; supernatant was removed; the precipitation of epidermal tissue was re-suspended using 10 mL 
PBS and was gently pippetted, followed by centrifugation at 1,200 rpm for 5 min; supernatant was discarded. 
Precipitation of epidermal tissue was suspended with 5-6 mL PBS containing 0.25% trypsin and gently pippetted; 
The suspension was incubated at 36.8±0.2℃ for 30-40 min, during which the suspension was slightly swayed twice; 
5-6 mL PBS was added, followed by gentle pippetting and centrifugation at 1,200 rpm for 5 min; supernatant was 
removed; another 10 mL PBS was used to suspend cell precipitation, followed by gentle pippetting and centrifugation 
at 1,200 rpm for 5 min; again, supernatant was disposed. Cell precipitation was suspended using hEMSCPCs medium 
[18-20 mL FBS (Si jiqing Ltd , China), 1 mL 100×non-essential amino acid (GIBCO, USA), 1 mL PBS containing 
L-glutamine 0.03 g/mL (GIBCO, USA), 150 μL solution containing 40,000 U/mL gentamycin (GUANGDONG 
SUCCHI PHARMACEUTICAL (GROUP) LTD.), added with DMEM (GIBCO, USA) with a glucose concentration 
of 4.5 g/L to a final volume of 100 mL; finally, hSCF is added to a final concentration of 2 ng/mL and hbFGF to a 
final concentration of 10 ng/mL (PERPOTECH, USA)] and gently pippetted and then transferred into a culture flask; 
a total of 3-4 culture flasks of 25 cm2 in volume were used for epidermal cells obtained from each specimen; each 
culture flask was added with 5-6 mL of medium; after being gently pippetted, the cells were placed and incubated at 
36.8±0.2℃、5%CO2 and 100% humidity; the flask remained unmoved within 48 hours; after that, medium was 
replaced, and un-adherent cells disposed; incubation was continued; during the next 5-10 days, medium would be 
replaced based on the degree of yellowing in the medium; within 7-10 days, small fusiform cells would appears and 
kept increasing in number thereafter; 2-3 weeks later, digestion solution [0.25% trypsin added to 0.02% EDTA at the 
ratio of 1:1 (GIBCO, USA)] could be used to digest and passage the cells; Epithelial-like cells might appear in a 
small number of specimens; however, small fusiform cells were extremely easy to detached from the culture plates, 
while epithelial-like cells were not; therefore epithelial-like cells could be limited by controlling the time of digestion. 
Isolated small fusiform cells were collected, and centrifuged at 1,200 rpm for 5 min, and supernatant was removed; 
cell precipitation was suspended using medium, followed by gentle pippetting; cells were counted; a number of 5×105 
cells were inoculated into a 25 cm2 culture flask for further incubation. During the first 30 passages, the cells grew 
very fast, and generally they could be passaged every 1.5-3 days at the ratio of 1:3. Karyotyping was performed at 
P30-32. 
 
Immunocytochemistry  
Sterilized cover slips of 22 × 22 mm2 were placed into Ф35mm plates; after being rinsed with PBS twice, the 
Ф35mm plates were placed into Ф100mm plates, which were added with a small amount of sterilized water. Digested 
hEMSCPCs were adjusted to a cell density of 5×104/mL using medium, and added onto Ф35mm plates pre-laid with 
cover slips, with 2 mL in each culture plates, followed by incubation for 2-3 days at 36.8±0.2, 5%CO2 and 100% 
humidity. During this incubation, medium was replaced based on the degree of yellowing in the medium.  
  
 
Cover slips adhered by cultured cells were gently rinsed thrice with PBS preheated at 36.8±0.2; cover slips used in 
immunohistochemical DAB staining of Nestin, Vimentin, β- tubulin, GFAP, CK19, CD10, CD3, CD19, CD16, 
CD45, CD34, CD31 and VEGF R2 (abcam, USA & Invitrogen, USA) were fixed using methanol over 20 min and 
then slightly rinsed with distilled water; subjected to 3%Triton x-100 over 20 min at room temperature and then 
slightly rinsed with PBS; treated with 3%H2O2 over 10 min at room temperature and again slightly rinsed with PBS; 
blocked with normal goat serum over 10 min, and were dried by shaking them; then corresponding primary antibody 
was added, followed by incubation at 37 for one hour and rinsing with PBS thrice, with 3 min in each time; A 
solution (intensifier) was added drop by drop, followed by incubation at 37 for 15 min; Again the cover slips were 
rinsed with PBS thrice, with 3 min in each time; B solution (Polymerized HRP-Anti Ms/Rb IgG) was added drop by drop, 
followed by incubation at 37 for 20 min and rinsing with PBS thrice, with 3 min in each time; DAB was added to 
develop the color over 10 min; the cover slips were then observed under microscope, and rinsed with tap water to 
terminate the reaction; counterstaining was achieved using Mayer`s hematoxylin over 1 min, followed by rinsing in 
tap water to blue the stain; the cover slips were left to dry, sealed and observed and photographed under regular 
optical microscope (Zeiss, Germany). Cover slips adhered by cultured cells used in immunohistochemical staining of 
CD90, CD73, CD105 (Santa Cruz, USA), HLA-DR and HLA-I (Invitrogen，USA) were rinsed with PBS, and 
immediately incubated with FITC-labeled antibody according to the protocol provided by reagent manufacturers, and 
then fixed over 1 min using pure methanol and glacial acetic acid at the ratio of 3: 1 pre-cooled at 4; They were 
then left to dry and counterstained with DAPI solution (Abbott Molecular Inc. USA) to achieve nuclear staining, and 
were blocked. They were left in room temperature for 30 min and then observed, scanned and photographed under 
laser confocal microscope (Zeiss, Germany)( DAPI : excitation wavelength 405nm, emission wavelength 461nm, FITC : 
excitation wavelength 488nm , emission wavelength 525nm ).   
 
Flow Cytometry Analysis  
After being passaged, the cells were further incubated for 40-48 hours, and digested with 0.25% trypsin-0.02% EDTA 
into single cell suspension. Following rinsing with PBS twice, it was re-suspended using a small amount of PBS, and 
divided into 1.5 mL EP tubes. Flow cytometry was performed for antibodies used; for directly labeled antibodies: 
mouse-anti-human CD73, CD34, HLA-DR monoclonal antibodies (BD, USA), mouse-anti-human CD45, CD3, CD 
19, CD16, HLA- (Invitrogen, USA), mouse-anti-human CD10, CD31, CD90, CD105, VEGF-R2, CK19 
monoclonal antibodies (Santa Cruz, USA), with isotype controls of PE-Isotype control, Percp-Isotype control, 
FITCIgG1-Isotype control and FITCIgG2-Isotype control (by the same suppliers as corresponding antibodies). For 
indirectly labeled antibodies, primary antibodies: mouse-anti-human Vimentin monoclonal antibody (abcam, USA), 
mouse-anti-human β- tubulin monoclonal antibody (Millipore, USA), rabbit-anti-human nestin polyclonal antibody 
and rabbit-anti-human GFAP polyclonal antibody (abcam, USA); secondary antibodies were: goat-anti-mouse-PE, 
goat-anti-rabbit-FITC (Southern Biotech, USA); cell fixation and permeabilization kit was used for intracellular 
antigen (Invitrogen, USA). All procedures were conducted according to protocols of the reagents; treatment tubes 
added with secondary antibody but not primary antibody were used as isotype control for indirectly labeled antibody. 
After the treatment, the specimens were subjected to detection in a flow cytometer (FACSaria, BD, USA), while data 
from flow cytometry were analyzed by FCS Express V3. Values for isotype controls were limited within 0%-1%.   
 
Make up Chimeras  
HEMSCPCs at P10-13 frozen in LN2 were thawed in warm water at the temperature of 35-37, and suspended with 
DMEM containing 10% FBS, followed by centrifugation at 1,200 rpm over 5 min; supernatant was removed. Cells 
were re-suspended using 0.5 mL DMEM without serum, placed in a 6-8 refrigerator for 10 min, and were then 
  
microscopically injected into mouse blastocoele. Each mouse blastocoeles was injected with 6-8 cells. Injected mouse 
embryos were incubated overnight at 36.8±0.2, 5%CO2 and 100% humidity. On the second day, well-developed 
embryos were transferred into the uterus of 2.5-day pseudo-pregnant mother mice. In 18±1 days, mouse pups would 
be born. Some of the pseudo-pregnant mice would not become pregnant or would experience miscarriage, while other 
might give birth to deformed pups, which would die soon. Among pups who survived for more than one month, male 
ones were excluded, while female ones were used for the detection. 
 
PCR of Human SRY  
To identify hEMSCPC-derived cells in the female mice, genomic DNA was extracted from tissue samples using the Biomiga EZgene 
TM Tissue gDNA Miniprep Kit. Genomic DNA from tissues was analyzed by human Y chromosome-specific DNA and the human 
SRY sequence was detected by a nested-PCR procedure using sequence specific primers (SRY primers: F1, 
5′-CAGTGTGAAACGGGAGAAAACAGT-3′; R1, 5′- CTTCCGACGAGGTCGATACTTATA-3′; F2, 5′- 
TGTAATTTCTGTGCCTCCTGGAAGAATGG-3′; and R2, 5′- GAAACGGGAGAAAACAGTAAAGGCAACGT -3′). In the first 
PCR, a 25 μl of PCR mixture with the primers F1 and R1 was used. After the initial denaturing step at 95 °C for 10 min, 35 cycles of 
amplification were performed, consisting of 30 s at 95 °C, 30 s at 65 °C, and 30 s at 72 °C, followed by a final single extension step at 
72 °C for 10 min. In the second PCR amplification reaction, the 25 μl reaction mixture contained the primers F2 and R2 and 0.5 μL of 
the first PCR product. The PCR conditions were similar to those used for the first PCR except for the cycles of amplification. In total, 
32 cycles were performed. As a control, GAPDH primers were used (F, 5′- TCACTCAAGATTGTCAGCAA -3′; R, 5′- 
AGATCCACGACGGACACATT -3′) with  the  annealing temperature at 55 °C for 27 cycles. The PCR products were separated by 
a  1.5% agarose gel.  
PCR MATERIALS: 
We used the Biomiga EZgene TM Tissue gDNA Miniprep Kit (Biomiga,Inc., San Diego, CA,USA), 2x Taq PCR Mix (Biomiga,Inc., 
San Diego, CA, USA), Biowerter Regular Agarose G-10 (Gene Company LTD., Hong Kong), and a Tprofessional standard Gradient 
Thermocycler (Biometra GmbH,Germany). Electrophoresis was run on a LIUYI, DYY-12 (BEIJING LIUYI INSTRUMENT 
FACTORY, CHINA) with a VILBER LOURMAT INFINITY gel formatter (Vilber Lourmat, France). An ultraviolet 
Spectrophotometer was purchased from Beckman-Coulter (Model DV800; Beckman Coulter, Inc. USA). 
 
FISH of Human Y for hEMSCPCs 
After being incubated for 24 hours, hEMSCPCs were replaced with medium containing 0.2ug/ml colcemid when 
cells were 70%-80% confluent; incubation was continued on at 36.8±0.2, 5%CO2 and 100% humidity for 2-2.5 
hours; medium containing colcemide was removed, and cells were rinsed with PBS twice; cells were digested, 
collected and counted as routine; rinsed with PBS once; cell precipitation was oscillated and blended using a vortex 
oscillator. An approximate of 2×106 cells were added into 3 mL 0.075 M KCl, gently blended and incubated at 37 
over 10 min; following centrifugation at 1,200 rpm for 5 min, supernatant was removed; cells were gently oscillated 
in a vortex oscillator to prevent cell lumping; an amount of 3 mL fixative solution freshly prepared with pure 
methanol and glacial acetic acid (3:1) was added while blending the suspension; after centrifugation at 1,200 rpm 
over 5 min, supernatant was removed; Cells were again blended gently by vortex oscillator and added with 3 mL 
fixative solution freshly prepared with pure methanol and glacial acetic acid (3:1) while being blended. After 
centrifugation at 1,200 rpm over 5 min, supernatant was removed; following a second gentle blending process, cells 
were added with fixative solution of pure methanol-glacial acetic acid (3:1) to a cell concentration of 1×106 cells/mL; 
Cell suspension was divided into EP tubes, with 100 µL in each tube. These tubes were then stored at -20℃ for 
subsequent use. Cells were transferred from -20℃ into room temperature, and cytospin (Shandon, Thermo Electron 
Corporation, UK)was performed at 2,000 rpm and moderate acceleration over 2 min; cell smears were air-dried; 
smears were soaked in 2×SSC/0.1%NP-40 rinsing solution (prepared based on the regimen provided by Abbott 
  
Molecular Inc. USA) preheated at 37 for 30 min; excessive solution on the smears was removed; gradient 
dehydration was performed in 70%, 85%, and 100% ethanol at room temperature, with 2 min in each gradient; the 
smears were air-dried, (the following processes were to be performed light-shielded) and added with 10 µL 
human-Y specific probe mixture (prepared based on the regimen provided by Abbott Molecular Inc. USA); covered 
with slips, the smears were subjected to co-denaturation over 6 to 7 min at 73±1; and then placed in a sealed humid 
container preheated at 42 for 16 hours; rinsed with 2×SSC/0.3%NP-40 solution (prepared based on the regimen 
provided by Abbott Molecular Inc. USA) preheated at 73±1 over 2 min and then transferred to 2×SSC/0.1%NP-40 
solution (prepared based on the regimen provided by Abbott Molecular Inc. USA) at room temperature for another 2 
min; excessive solution was removed from the smears, which were then air-dried and counterstained with 10 µL 
DAPI solution (Abbott Molecular Inc. USA) and blocked by upturning the smears; these smears were observed and 
photographed under laser confocal microscope (Zeiss, Germany) using blue-light(excitation wavelength 405nm, 
emission wavelength461nm) and red-light (excitation wavelength 543nm, emission wavelength588nm) 30 min later.  
 
FISH of Human Y for Chimeras' blood 
An amount of 200 µL anti-coagulated blood was obtained from mice; added with 3 mL of 0.83% NH4Cl solution 
pre-cooled at 4 and then gently pippetted; it was then left to stand at 37 for 15 min; 4 mL PBS was added, 
followed by gentle pippetting; after centrifugation at 1,200 rpm over 5 min, supernatant was removed; 10 mL PBS 
was added, followed by gentle pippetting; after centrifugation at 1,500 rpm over 5 min, supernatant was removed; 
cell precipitation was oscillated and blended using a vortex oscillator. Processes hereafter were the same as in FISH 
of Human Y for hEMSCPCs. 
 
Immunofluorescence Staining & FISH of Human Y for Chimeras' blood 
Antibody would be used only when no cross-reactions were seen in tests performed in normal negative female mice. 
 
An amount of 200 µL anticoagulated blood was obtained from mice, added with 3 mL of 0.83% NH4Cl solution 
pre-cooled at 4 and gently pippetted; it was then left to stand at 37 for 15 min; 4 mL PBS was added, followed by 
gentle pippetting; after centrifugation at 1,200 rpm over 5 min, supernatant was removed; 10 mL PBS was added, 
followed by gentle pippetting; after centrifugation at 1,500 rpm over 5 min, supernatant was removed; added with 
100 µL PBS, the suspension was gently pippetted to nicely suspend the cells; (the following processes are to be 
performed light-shielded) added with FITC-labeled anti-human monoclonal antibody CD3,CD19,CD16 (Invitrogen, 
USA ,dosage was based on the formula provided by manufacturers) and gently pippetted; it was incubated at room 
temperature for 30-40 min (performed according to the procedures provided by reagent manufacturers); After 2 
cycles of PBS rinsing and centrifugation at 1,800 rpm for 5 min, cell precipitation was suspended using a vortex 
oscillator; 1 mL fixative solution of pure methanol and glacial acetic acid (3:1) was added drop by drop while cell 
suspension was being gently blended; after centrifugation at 2,000 rpm over 5 min, supernatant was removed; 100 µL 
fixative solution of pure methanol and glacial acetic acid (3:1) was added drop by drop while cell suspension was 
being gently blended; cytospin (Shandon, Thermo Electron Corporation, UK) was performed at 2,000 rpm and 
moderate acceleration in 2 min; the smears were air-dried. Processes hereafter were the same as in FISH of Human 
Y for hEMSCPCs. Finally, smears were observed and photographed under laser confocal microscope (Zeiss, 
Germany) using blue-, green- and red-light (excitation wavelength 405nm/488nm/543nm, emission 
wavelength461nm/525nm/588nm).  
 
Immunofluorescence Staining & FISH of Human Y for Chimeras' Brain, Heart, Lung, Spleen, Liver & Kidney 
Antibody would be used only when no cross-reactions were seen in tests performed in normal negative female mice. 
The antibodies used in this trial were as following: Primary antibodies were rabbit anti-human β-Ⅲ tubulin polyclonal 
  
antibody and rabbit anti-human MAP2 monoclonal antibody（abcam，USA）,FITC conjugated goat anti-rabbit 
(SouthernBiotech, USA) served as the secondary antibody, FITC-labeled mouse or rabbit anti-human monoclonal 
antibody Tropolin I,SP-C,CD31, CD16,ALB, VEGF R2（Invitrogen, USA & Santa Cruz, USA & BD, USA）. 
 
Tissues of brain, heart, lung, spleen, liver and kidney from female mice to be examined were embedded with OCT 
compound (Sakura Finetek, USA), and stored at -20℃ for subsequent use. Tissues of brain, heart, lung, spleen, liver 
and kidney with positive nested-PCR results were subjected to frozen section at the slice thickness of 4 µm; the slices 
were air-dried and then OCT gel was removed; to improve adhesion of tissue slices and to adequately spread tissue 
structures, cytospin (Shandon, Thermo Electron Corporation, UK) was performed at 2,000 rpm and moderate 
acceleration over 2 min; (the following processes are to be performed light-shielded) slices were incubated with 
FITC-antibody (directly labeled) or primary antibody (indirectly labeled) at room temperature for 40 min (performed 
according to the procedures provided by reagent manufacturers); rinsed 3-4 times with PBS pre-cooled at 6-8℃; for 
indirectly labeled antibody, incubation was continued on with FITC-second antibody at room temperature for 30 min 
(performed according to the procedures provided by reagent manufacturers); rinsed 3-4 times with PBS pre-cooled at 
6-8℃. After incubation with antibodies, tissue slices were to be air-dried; soaked in 2×SSC/0.1%NP-40 solution 
(prepared based on the regimen provided by Abbott Molecular Inc. USA) preheated at 37 for 30 min; excessive 
solution on the slices was removed; and the slices were subjected to gradient dehydration in 70%, 85% and 100% 
ethanol at room temperature, with 2 min in each gradient; slices were air-dried, added with 10 µL human-Y specific 
probe mixture (prepared based on the regimen provided by Abbott Molecular Inc. USA); covered with a cover slip, 
the slices underwent co-denaturation at 73±1 in 6-7 min; and then placed in a sealed humid container pre-heated at 
42 for 16 hours; rinsed in 2×SSC/0.3%NP-40 solution (prepared based on the regimen provided by Abbott 
Molecular Inc. USA) preheated at 73±1 over 2 min; transferred into 2×SSC/0.3%NP-40 solution (prepared based 
on the regimen provided by Abbott Molecular Inc. USA) at room temperature for 2 min; excessive solution on the 
slices was removed and the slices air-dried, counterstained by dripping 10-15 µL DAPI solution (Abbott Molecular 
Inc. USA) onto the cover slips, and blocked by upturning the slices; these slice were observed and photographed 
under laser confocal microscope (Zeiss, Germany) using blue-, green- and red-light(excitation wavelength 
405nm/488nm/543nm, emission wavelength461nm/525nm/588nm) 30 min later. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Table 
 
Supplementary Table 1. Dynamic expression of specific markers in cultured hEMSCPCs before  
passage 30 as determined by flow cytometry analysis                
 
Marker P2 P10 P20 P30 P* 
CD73 97.975±0.689 98.438±0.574 98.713±0.296 97.625±0.697 1.182 
CD90** 62.025±11.563 91.863±1.387a 90.650±3.659b 94.825±2.015c 0.002 
CD105 46.700±7.356 59.225±8.041 59.075±4.730 65.813±3.793 0.171 
Vimentin 77.225±5.653 88.425±2.884 87.8±4.413 86.475±4.463 0.271 
Nestin*** 62.263±9.913 87.325±2.978A 92.875±1.627B 87.163±2.246C 0.003 
GFAP 0.325±0.269 1.3±0.88 1±0.528 1.975±1.062 0.347 
β-III Tubulin 3.113±1.367 6.288±2.609 4.525±1.607 4.488±2.434 0.765 
CD10 0.838±0.404 3.488±1.630 2.963±0.968 2.025±0.652 0.227 
CK19 0.225±0.156 0.188±0.174 0.35±0.151 0.138±0.089 0.265 
CD34 0.388±0.090 0.575±0.185 0.15±0.05 0.413±0.146 0.138 
CD45 0.05±0.038 0.025±0.025 0.038±0.018 0.15±0.07 0.134 
CD3 0.375±0.096 0.4±0.08 0.25±0.06 0.763±0.293 0.093 
CD19 0.125±0.059 0.063±0.042 0.063±0.026 0.1±0.033 0.649 
CD16 0.1±0.027 0.038±0.018 0.163±0.068 0.175±0.077 0.116 
CD31 0 0.513±0.309 0.425±0.256 0.438±0.180 0.241 
VEGFR2 0 0.7±0.411 0.538±0.263 0.7±0.211 0.139 
HLA-DR 4.438±3.784 0.05±0.032 0.038±0.026 0 0.284 
HLA-I**** 27.563±10.104 12.113±7.633 6.95±5.576# 8.688±5.151 0.023 
* SPSS 13.0 was used for statistical analysis. Data from FACS are presented as mean ± standard error of the mean (SEM). Results 
were analyzed by two-way ANOVA with Bonferroni multiple comparison post-test for more than two groups. Differences were 
considered statistically significant when P < 0.05. n=8. 
** hEMSCPCs at passage 2 had lower CD90 expression compared to passages 10, 20, and 30. a The comparison between passage 2 
and passage 10, P= 0.009, b The comparison between passage 2 and passage 20, P= 0.013, c The comparison between passage 2 
  
and passage 30, P=0.004. 
*** hEMSCPCs at passage 2 had lower nestin expression compared to passages 10, 20, and 30. A P= 0.021, B P= 0.004, C P= 0.022. 
**** hEMSCPCs at passage 2 had higher HLA-I expression compared to passage 20, #P= 0.035. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Table 2.. Positive organs based on nested PCR of human SRY genes 
 
Number Blood Heart Brain Lung Kidney Spleen Liver 
6   + + +   
8 +       
10 +       
11 +       
13 +       
15 +       
17 +       
18   +   +  
19 + + +     
20 + +  +    
21 +       
22 +       
24      +  
32 + +      
34 +       
36  +   +  + 
37   + + +  + 
38      +  
39 +       
41    +    
42 +   +    
45 +       
  
50    +    
52  +   +  + 
53    +    
63  +      
64      +  
66    +    
      Neither normal negative mice (number 1 to number 5) nor mice with 7 negative organs are shown.  
hEMSCPCs were most widely distributed in blood, then lung, followed by heart, brain, spleen,  
kidney, and finally liver (the lowest). 
 
 
 
 
 
 
 
Supplementary Figure Legends 
 
 
Supplementary Figure 1. Karyotype of hEMSCPCs. Chromosome detection of hEMSCPCs between passages 30 
to 32 confirmed the karyotype as 46, XY. 
 
 
  
 
Supplementary Figure 2. Human Y FISH for hEMSCPCs and the cells from positive caudal vein blood of 
female chimeras Human Y chromosome is seen as red spots. hEMSCPCs have positive human Y (a); the cells from 
caudal vein blood of positive female chimeras had differently shaped nuclei: sublobe nucleus (b), giant nucleus (c), 
spherical nucleus (d), and renal type nucleus (e). 






